CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy

J. Dallmann; J. Freitag; C. Jung; K. Khinvasara; L. Merz; D. Peters; M. Schork; J.D. Beck

Immuno-Oncology and Technology (Dec 2023)

CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy

J. Dallmann,
J. Freitag,
C. Jung,
K. Khinvasara,
L. Merz,
D. Peters,
M. Schork,
J.D. Beck

Affiliations

J. Dallmann: Immunotherapies & Preclinical Research, BioNTech SE, Mainz
J. Freitag: TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany
C. Jung: Immunotherapies & Preclinical Research, BioNTech SE, Mainz; BioNTech Cell & Gene Therapies GmbH, Mainz; TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany
K. Khinvasara: TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany
L. Merz: TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany
D. Peters: Immunotherapies & Preclinical Research, BioNTech SE, Mainz
M. Schork: TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany
J.D. Beck: Immunotherapies & Preclinical Research, BioNTech SE, Mainz; Correspondence to: Dr J. D. Beck, BioNTech SE, An der Goldgrube, Mainz 1255131, Germany. Tel: +49 6131 90843712

Journal volume & issue: Vol. 20
p. 100397

Abstract

Read online

The Association for Cancer Immunotherapy (CIMT) celebrated the 20th anniversary of the CIMT Annual Meeting. CIMT2023 was held 3-5 May 2023 in Mainz, Germany. 1051 academic and clinical professionals from over 30 countries attended the meeting and discussed the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2023.

Published in Immuno-Oncology and Technology

ISSN: 2590-0188 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/immuno-oncology-and-technology

About the journal

Abstract

Keywords